NCT01916304View on ClinicalTrials.gov

Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation

PHASE2CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Hypothyroidism

Interventions

DRUG

Levothyroxine sodium new formulation

Levothyroxine tablets

Trial Locations (1)

Unknown

Leuven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY

NCT01916304 - Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation | Biotech Hunter | Biotech Hunter